In Bermuda, Specialty MGA Capacity Outruns Carrier Appetite

Bermuda's specialty liability market is running ahead of the carriers that are supposed to absorb its risk. MGA capacity is being raised faster than carriers will deploy it, and the gap shows up in claims buildouts, IPO proceeds, and regulatory frameworks that treat parametric risk transfer as a substance question. This piece settles what that gap means for anyone watching binding authorities and liability pricing.

Bermuda MGA Capacity Outpaces Carrier Appetite

Managing general agents in Bermuda have spent the past two years raising capacity from reinsurers and specialty carriers. The pitch is straightforward: niche liability books, disciplined underwriting, and fee income that does not sit on the MGA's balance sheet. Carriers sign binding authorities because they want premium volume without building the underwriting infrastructure themselves.

The problem is that carrier appetite for liability lines has narrowed at the same time. General liability, professional lines, and management liability have all seen claims trends that make boards cautious. An MGA can raise a capacity commitment in weeks. A carrier deciding how much of that commitment to actually deploy moves slower, and often deploys less than the headline number suggests.

That mismatch is the defining feature of the current Bermuda market. Capacity announcements are not the same as capacity deployed. A related piece on this site, Check a Specialty MGA's Carrier Panel Before Renewing Binding Authority, makes the point that the panel behind the paper matters more than the paper itself.

Insurance-linked securities (ILS) issuance has added another layer. Bermudian special purpose insurers now host a meaningful share of the catastrophe bond market, and the collateralised reinsurance sidecar format has become a standard tool for carriers seeking to lay off liability risk. The sidecar structure lets a carrier cede a quota share of a defined book to investors, who post collateral and take the underwriting result. For an MGA, that means the capacity behind a binding authority may itself be tranched and syndicated, which complicates any assumption that the carrier on the paper is the ultimate risk bearer. The practical consequence is that an MGA's ability to write business depends less on a single carrier's appetite and more on whether the underlying risk can be distributed to capital markets at a spread investors will accept. When ILS spreads widen, carrier appetite narrows, and the MGA feels it first.

Relm Insurance and the Claims Buildout

Relm Insurance, which writes coverage for businesses in emerging and specialised sectors, named Mike Morales as Head of Claims in September 2026, based in New York. The appointment covers claims across both insurance and reinsurance, according to ReinsuranceNe.ws. That dual scope is the signal worth reading.

An MGA or specialty insurer that builds a claims function spanning insurance and reinsurance is preparing for severity, not just frequency. Emerging-sector liability claims tend to arrive late and arrive contested. A dedicated claims lead with reinsurance visibility is a capacity signal, because reinsurers price the claims handling they can see.

The timing is hedged by the reporting itself. The appointment was announced in September 2026, and the operational buildout that follows will take quarters, not weeks. Readers should treat the hire as an intent marker rather than proof that claims capacity has already changed.

Orion180 IPO and Capital Flow

Orion180, a technology-focused specialty insurance group, priced its initial public offering at $12 a share, raising $240m in gross proceeds from 20 million Class A shares, per ReinsuranceNe.ws. Underwriters could add roughly $36m through the overallotment option, taking the potential total near $276m.

Public markets are rewarding specialty focus with real money. That matters for the MGA-versus-carrier question because IPO proceeds give a specialty group a balance sheet of its own, reducing its dependence on third-party capacity. When more specialty writers hold their own paper, the MGA capacity that carriers were already hesitant to deploy faces more competition for the same risk.

The counterargument is that IPO proceeds are a market indicator, not a deployment plan. A listed specialty insurer still has to choose which lines to write, and liability lines with contested claims trends are not automatically the first call on new capital.

BMA Parametric Framework and Substance

The Bermuda Monetary Authority has confirmed that contracts under its proposed Parametric Special Purpose Insurer framework can be structured as reinsurance, derivatives, or swaps, provided the underlying risk transfer meets statutory and regulatory requirements. Artemis.bm reported the substance-over-form position in September 2026.

The BMA launched its consultation in January, and the framework is still working through that process. The direction is clear enough to matter: Bermuda is building a regulatory lane for parametric risk that does not force every structure into a reinsurance mould. For liability and specialty writers, that expands the set of tools available to transfer defined triggers.

Parametric structures are not a fix for liability severity. They work best where a trigger is observable and correlated with loss. Liability claims rarely have that property, so the PSPI framework is more relevant to property and catastrophe-linked risk than to the professional lines that dominate MGA capacity today.

Litigation Funding and Liability Pressure

Insurance executives joined more than 200 companies in a letter to a federal court rules committee urging a third-party litigation funding disclosure requirement. Carrier Management reported the letter was submitted on September 14 to the Advisory Committee on Civil Rules, organised in part by the Lawyers for Civil Justice.

Third-party litigation funding changes the economics of liability claims. A funded claimant can sustain a case longer, reject earlier settlement offers, and pursue theories that an unfunded plaintiff might abandon. For carriers pricing general liability, professional lines, and management liability, that shifts the severity distribution rather than the frequency.

Disclosure would not eliminate the pressure, and the letter is a request, not a rule. Still, carrier appetite is sensitive to claim trends, and a disclosure requirement that makes funding visible would give underwriters a new input. This site has argued in Reinsurers Reprice Disability Cover as Mutuals Retreat From the Pool that liability-side claim trends move pricing faster than capital availability does.

Practical Takeaways for Specialty MGA Watchers

Track the gap between announced MGA capacity and actual carrier deployment, not the headline commitment. Ask for the panel and the signed lines behind any binding authority before you treat capacity as real.

Watch the BMA's PSPI consultation outcome for how parametric structures get classified. The substance-over-form position matters for anyone structuring triggers, even if liability lines are not the first use case.

Monitor the litigation-funding disclosure docket for signs that funded claims are becoming visible to underwriters. A disclosure rule would change what carriers can price, and pricing follows visibility.

Treat claims buildouts, like Relm's Head of Claims appointment, as a capacity signal rather than a cost line. Claims infrastructure is what reinsurers look at when they decide how much liability risk to accept.

Read IPO proceeds as a market indicator with a lag, not as immediate deployment. Orion180's raise tells you capital markets like specialty focus; it does not tell you which lines get written next quarter.

This article is informational and not personalised professional advice. It reflects public reporting and general market structure, and readers should verify operational details with the relevant counterparties before acting.

How Reinsurance Pricing Filters Through to MGA Economics

Reinsurance pricing sets the floor under MGA economics. When a carrier cedes a portion of an MGA's book, the reinsurance cost is a direct input to the MGA's commission and profit-share calculation. If reinsurance rates rise, the MGA's margin compresses unless it can push the cost back to the insured through higher primary rates. In a soft market, that pushback is difficult, and the MGA absorbs the difference.

This mechanism explains why capacity announcements can be misleading. An MGA might secure a large binding authority, but if the reinsurance behind it is priced at a level that leaves no room for the MGA's fee, the capacity is not economically usable. The MGA will write less than the authority allows, or it will write at a loss to maintain market presence. Neither outcome is sustainable.

Watch the spread between primary liability rates and reinsurance rates. When that spread narrows, MGA capacity becomes more expensive to deploy, and carriers become more selective about which MGAs they support. The current Bermuda market shows signs of that narrowing in professional lines, where claims trends have pushed reinsurance pricing up while primary rates remain competitive.

Capacity Constraints and the Claims Triage Problem

Claims capacity is not just a matter of hiring adjusters. It involves systems, data, and the ability to triage a growing volume of complex liability claims. An MGA that raises capacity without corresponding investment in claims infrastructure creates a bottleneck that eventually forces carriers to reconsider their support.

The bottleneck often appears first in severity claims. These require specialised expertise, and if the MGA lacks that expertise, claims drag on, legal costs rise, and the ultimate loss cost exceeds expectations. Reinsurers track this. They see the development patterns, and they adjust their pricing or their appetite accordingly.

This is why the Relm appointment matters. It signals that at least one specialty writer is addressing the claims side before it becomes a constraint. But one appointment does not change the market. The broader question is whether other MGAs and their carrier partners are making similar investments, or whether they are relying on capacity commitments that outpace their operational readiness.

What to Watch Next

The BMA's PSPI consultation outcome will clarify how parametric structures fit into Bermuda's regulatory framework. That clarity could attract new capital to parametric risk, but it is unlikely to solve the liability capacity mismatch directly. Parametric triggers do not map neatly to liability claims, so the framework's impact on professional lines will be indirect.

Litigation funding disclosure remains a wild card. If a disclosure requirement advances, underwriters gain visibility into funded claims, which could improve pricing accuracy. If it stalls, the uncertainty persists, and carriers will continue to price liability with a conservative bias.

IPO activity is another indicator. If more specialty insurers go public, the balance of power shifts further toward those with their own balance sheets. MGAs that depend on third-party capacity will face stiffer competition for carrier attention, and the gap between announced capacity and deployed capacity may widen.

Finally, watch the claims buildout trend. If more specialty writers follow Relm's lead and invest in claims infrastructure, the capacity that carriers are willing to deploy could increase. If claims capacity remains a bottleneck, the gap will persist, and MGA growth will be constrained by operational reality rather than capital availability.